These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35605406)

  • 1. Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral 3CLpro enzymes.
    Sugamoto K; Tanaka YL; Saito A; Goto Y; Nakayama T; Okabayashi T; Kunitake H; Morishita K
    Biochem Biophys Res Commun; 2022 Jul; 615():56-62. PubMed ID: 35605406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of adult T-cell leukemia cell proliferation by polymerized proanthocyanidin from blueberry leaves through JAK proteolysis.
    Ichikawa T; Sugamoto K; Matsuura Y; Kunitake H; Shimoda K; Morishita K
    Cancer Sci; 2022 Apr; 113(4):1406-1416. PubMed ID: 35100463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of Enteric Viruses by Blueberry Juice and Blueberry Proanthocyanidins.
    Joshi SS; Howell AB; D'Souza DH
    Food Environ Virol; 2016 Dec; 8(4):235-243. PubMed ID: 27299641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal Variation and Mean Degree of Polymerization of Proanthocyanidin in Leaves and Branches of Rabbiteye Blueberry (
    Koga Y; Setoguchi Y; Sugamoto K; Goto Y; Hirano T; Kunitake H
    Plants (Basel); 2024 Jul; 13(13):. PubMed ID: 38999703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Proanthocyanidin Content in Rabbiteye Blueberry (
    Toyama Y; Fujita Y; Toshima S; Hirano T; Yamasaki M; Kunitake H
    Plants (Basel); 2023 Feb; 12(4):. PubMed ID: 36840296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral effects of blueberry proanthocyanidins against Aichi virus.
    Joshi SS; Howell AB; D'Souza DH
    Food Microbiol; 2019 Sep; 82():202-208. PubMed ID: 31027775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proanthocyanidin from blueberry leaves suppresses expression of subgenomic hepatitis C virus RNA.
    Takeshita M; Ishida Y; Akamatsu E; Ohmori Y; Sudoh M; Uto H; Tsubouchi H; Kataoka H
    J Biol Chem; 2009 Aug; 284(32):21165-76. PubMed ID: 19531480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection.
    Dampalla CS; Zheng J; Perera KD; Wong LR; Meyerholz DK; Nguyen HN; Kashipathy MM; Battaile KP; Lovell S; Kim Y; Perlman S; Groutas WC; Chang KO
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34210738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-chymotrypsin-like protease in SARS-CoV-2.
    Al Adem K; Ferreira JC; Villanueva AJ; Fadl S; El-Sadaany F; Masmoudi I; Gidiya Y; Gurudza T; Cardoso THS; Saksena NK; Rabeh WM
    Biosci Rep; 2024 Aug; 44(8):. PubMed ID: 39036877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extension.
    Fuchs E; Rudnik-Jansen I; Dinesen A; Selnihhin D; Mandrup OA; Thiam K; Kjems J; Pedersen FS; Howard KA
    Acta Biomater; 2022 Nov; 153():411-418. PubMed ID: 36162760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blueberry proanthocyanidins against human norovirus surrogates in model foods and under simulated gastric conditions.
    Joshi S; Howell AB; D'Souza DH
    Food Microbiol; 2017 May; 63():263-267. PubMed ID: 28040178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Polyphenols, 1,2,3,4,6-O-Pentagalloyglucose and Proanthocyanidins, as Broad-Spectrum Anticoronaviral Inhibitors Targeting Mpro and RdRp of SARS-CoV-2.
    Jin YH; Lee J; Jeon S; Kim S; Min JS; Kwon S
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the Adult T-Cell Leukemia Inhibitory Activity of Blueberry Leaves/Stems Using Direct-Injection Electron Ionization-Mass Spectrometry Metabolomics.
    Kai H; Okada Y; Goto Y; Nakayama T; Sugamoto K; Ogawa K; Yamasaki M; Morishita K; Matsuno K; Kunitake H
    Plants (Basel); 2022 May; 11(10):. PubMed ID: 35631768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents.
    Mody V; Ho J; Wills S; Mawri A; Lawson L; Ebert MCCJC; Fortin GM; Rayalam S; Taval S
    Commun Biol; 2021 Jan; 4(1):93. PubMed ID: 33473151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents.
    Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B
    J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Natural Bioactive Peptide from
    Wang Y; Wang Q; Chen X; Li B; Zhang Z; Yao L; Liu X; Zhang R
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
    Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
    Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
    Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
    Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.